HIA
REGN icon

HFM Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

HFM Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.37K Buy
7
+5
+250% +$3.4K ﹤0.01% 220
2026
Q1 		$1.54K Buy
2
+1
+100% +$766 ﹤0.01% 283
2025
Q4 		$772 Hold
1
– – ﹤0.01% 546
2025
Q3 		$562 Hold
1
– – ﹤0.01% 605
2025
Q2 		$525 Buy
+1
New +$558 ﹤0.01% 634

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HFM Investment Advisors's REGN Position: Q2 2026 in Review

HFM Investment Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 250% in Q2 2026, buying an estimated $3.4K and bringing the position to 7 shares worth $4.37K. The position accounts for ﹤0.01% of the portfolio, ranked #220.

HFM Investment Advisors first reported a position in REGN in Q2 2025 and has held it in 5 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • HFM Investment Advisors held 7 shares of Regeneron Pharmaceuticals worth $4.37K as of Q2 2026.
  • HFM Investment Advisors bought 5 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $3.4K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #220 holding.
  • HFM Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.